Trump Announces Pricing Deals With Nine Drugmakers
The companies were the latest to agree to sell drugs [...]
F.D.A. Turmoil Keeps Spotlight on Its Commissioner
The agency’s high-level turnover and conflicting policy decisions on drug [...]
Ipsen’s oral small molecule…
Ipsen’s oral small molecule failed to reduce the progression of [...]
Updates on DTC advertising and DTP…
Updates on DTC advertising and DTP programs, as well as [...]
After a series of ownership…
After a series of ownership changes, Andexxa is slated to [...]
The Elevidys-related manufacturing…
The Elevidys-related manufacturing shortfalls were described in one of two [...]
Sixteen months after luring former…
Sixteen months after luring former Roche dealmaker James Sabry, M.D., [...]
As the FDA steadily churns out a…
As the FDA steadily churns out a stream of untitled [...]
Amgen, Boehringer Ingelheim,…
Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GSK, Merck [...]
Venture capital firm Aditum Bio is…
Venture capital firm Aditum Bio is going all-out for a [...]